Widening the Therapeutic Window in the Management of Parkinson’s Disease

Mar 13, 2024, 01:55 PM

Headliner
Share
Subscribe
Expert neurologists discuss strategies to widen the therapeutic window of Parkinson’s disease and options available to treat dyskinesia, providing better control of Parkinson’s disease.
Share
Subscribe
Next
Personalizing Dry Eye Disease Management
Top episodes
Paradigm Shift in Parkinson’s Disease Diagnosis
by MEDCast
Faricimab versus High-Dose Aflibercept for the Treatment of Neovascular AMD and DME
by MEDCast
Generational Trends and Innovations in Retinal Disease Care
by MEDCast